- Citations, last 5 years
- 34.1k
- Works, last 5 years
- 1 655
- h-index
- 548
- Scientists listed
- 0
- Grants since 2016
- 573
Grants received
2018 · research · WWDAIA
Development of Tau-Lowering Small Molecule Drugs
Lennart Mucke · Gladstone Institutes · funded by Alzheimer's Association
2018 · career development · K01
Synaptic mechanisms of tau-mediated pathogenesis in human iPSC-derived neurons
Tara Tracy · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Potential and Mechanisms of Tau Reduction in Autism Models
Lennart Mucke · Gladstone Institutes · funded by National Institutes of Health
2018–2021 · grant · ALSRP
Validating UBC9 as a Molecular Target to Develop a Therapy for All Forms of ALS
Steven Finkbeiner · Gladstone Institutes · funded by Congressionally Directed Medical Research Programs
2018–2023 · research · R00
Functional characterization of the Alzheimer's disease Epigenome
Michael Ryan Corces · Gladstone Institutes · funded by National Institutes of Health
2018–2021 · research · R61
Harnessing the RNA-Binding Properties of Cas13a for HIV-1 Self-Testing
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · RF1
Optogenetic dissection of cellular and circuit mechanisms of network dysfunction and amyloid deposition in mouse models of Alzheimer's disease in vivo
Jorge J Palop · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · R00
Functional characterization of the Alzheimer's disease Epigenome
Michael Ryan Corces · Gladstone Institutes · funded by National Institutes of Health
2018–2021 · career development · K99
Role of Dopamine and Basal Ganglia Circuits in Integrating Costs and Benefits for Action
Christopher H Donahue · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · grant · Continuing Grant
Collaborative Research - Combining Heterogeneous Data Sources to Identify Genetic Modifiers of Diseases
Steven Finkbeiner · Gladstone Institutes · funded by National Science Foundation
2018–2023 · research · R01
Therapeutic Potential and Mechanisms of Tau Reduction in Autism Models
Lennart Mucke · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
Todd C Mcdevitt · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Potential and Mechanisms of Tau Reduction in Autism Models
Lennart Mucke · Gladstone Institutes · funded by National Institutes of Health
2018–2020 · research · R56
ApoE2 and Alzheimer's Disease: Structural and Functional Roles in CNS Metabolism
Robert W. Mahley · Gladstone Institutes · funded by National Institutes of Health
2018–2019 · research · Drug Discovery
Novel human FTLD neuron and microglia cell models for drug discovery
Steven Finkbeiner · Gladstone Institutes · funded by Alzheimer's Drug Discovery Foundation
2017–2022 · research · R01
Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse
Warner C. Greene · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
Study ApoE4's Effects on Hippocampal Network Activity in Alzheimer's Disease
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2017–2021 · research · R01
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2017–2021 · research · R01
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · program · P01
Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption
Warner C. Greene · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · RF1
Dysfunction of the Autophagy-Lysosomal Pathway as a Common Mechanism of Neurodegeneration
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
Study ApoE4's Effects on Hippocampal Network Activity in Alzheimer's Disease
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2017–2018 · research · R01
Tau acetylation in Alzheimer's disease
Li Gan · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
ApoE Genotype-Directed Drug Repositioning and Combination Therapy for Alzheimer's Disease
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse
Warner C. Greene · Gladstone Institutes · funded by National Institutes of Health
2017 · fellowship · Scientist Development Grant
Mechanisms of GATA4 Gene Regulation in Human Cardiogenesis
Yensin Ang · Gladstone Institutes · funded by American Heart Association
2017–2022 · research · R01
Study ApoE4's Effects on Hippocampal Network Activity in Alzheimer's Disease
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
ApoE Genotype-Directed Drug Repositioning and Combination Therapy for Alzheimer's Disease
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2017–2023 · program · P01
Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption
Nadia R Roan · Gladstone Institutes · funded by National Institutes of Health
2017–2021 · research · R01
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2017–2024 · research · R37
Rare Variant Whole Genome Analysis and iPSC Validation of Putative Genetic Modifiers of Huntington Disease
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2017–2024 · research · R37
Rare Variant Whole Genome Analysis and iPSC Validation of Putative Genetic Modifiers of Huntington Disease
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2017–2021 · research · R37
Rare Variant Whole Genome Analysis and iPSC Validation of Putative Genetic Modifiers of Huntington Disease
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2017–2021 · research · R01
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
Study ApoE4's Effects on Hippocampal Network Activity in Alzheimer's Disease
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
ApoE Genotype-Directed Drug Repositioning and Combination Therapy for Alzheimer's Disease
Yadong Huang · Gladstone Institutes · funded by National Institutes of Health
2017–2022 · research · R01
Tau acetylation in Alzheimer's disease
Li Gan · Gladstone Institutes · funded by National Institutes of Health
2017 · research · AARF
Microglial modulation of neural activities in models of Alzheimer’s disease
Melanie Das · Gladstone Institutes · funded by Alzheimer's Association
2017–2019 · training · Predoctoral Fellowship
Transcription Factor Acetylation Regulates BRD4 Dynamics During Innate Immune Activation
Sarah Mcmahon · Gladstone Institutes · funded by American Heart Association